BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3462341)

  • 1. Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture.
    Blask DE; Hill SM
    J Neural Transm Suppl; 1986; 21():433-49. PubMed ID: 3462341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
    Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
    Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture.
    Hill SM; Blask DE
    Cancer Res; 1988 Nov; 48(21):6121-6. PubMed ID: 3167858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin and mammary pathological growth.
    Cos S; Sánchez-Barceló EJ
    Front Neuroendocrinol; 2000 Apr; 21(2):133-70. PubMed ID: 10764528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture.
    Biswas R; Vonderhaar BK
    Cancer Res; 1987 Jul; 47(13):3509-14. PubMed ID: 3581086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of melatonin and all-trans retinoic acid on the proliferation and induction of the apoptotic pathway in the culture of human breast cancer cell line MCF-7.
    Czeczuga-Semeniuk E; Wołczyński S; Anchim T; Dziecioł J; Dabrowska M; Pietruczuk M
    Pol J Pathol; 2002; 53(2):59-65. PubMed ID: 12140868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation.
    Jawed S; Kim B; Ottenhof T; Brown GM; Werstiuk ES; Niles LP
    Eur J Pharmacol; 2007 Mar; 560(1):17-22. PubMed ID: 17303109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological melatonin inhibition of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway.
    Blask DE; Wilson ST; Zalatan F
    Cancer Res; 1997 May; 57(10):1909-14. PubMed ID: 9157984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.
    Cos S; Martínez-Campa C; Mediavilla MD; Sánchez-Barceló EJ
    J Pineal Res; 2005 Mar; 38(2):136-42. PubMed ID: 15683469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatic effects of the pineal gland.
    Kerenyi NA; Pandula E; Feuer GM
    Drug Metabol Drug Interact; 1990; 8(3-4):313-9. PubMed ID: 2099893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach.
    Girgert R; Bartsch C; Hill SM; Kreienberg R; Hanf V
    Neuro Endocrinol Lett; 2003 Dec; 24(6):440-4. PubMed ID: 15073572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies.
    Horwitz KB; Freidenberg GR
    Cancer Res; 1985 Jan; 45(1):167-73. PubMed ID: 3838085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sulfhydryl compounds on cancer cell lines: I: N-(2-mercaptopropionyl)-glycine exerts antiproliferating effects and antagonizes the stimulating effect of prolactin on MCF-7 human breast cancer cells.
    Malamas FM; Thomas CG; Stefos T; Evangelou A
    In Vivo; 2007; 21(2):329-32. PubMed ID: 17436584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
    Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
    J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative action of melatonin on human prostate cancer LNCaP cells.
    Moretti RM; Marelli MM; Maggi R; Dondi D; Motta M; Limonta P
    Oncol Rep; 2000; 7(2):347-51. PubMed ID: 10671684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.
    Figueroa JA; Sharma J; Jackson JG; McDermott MJ; Hilsenbeck SG; Yee D
    J Cell Physiol; 1993 Nov; 157(2):229-36. PubMed ID: 7693722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient inhibition of synergistically insulin-like growth factor-1- and bisphenol A-induced poliferation of estrogen receptor alpha (ERalpha)-positive human breast cancer MCF-7 cells by melatonin.
    Ishido M
    Environ Sci; 2004; 11(3):163-70. PubMed ID: 15750583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells.
    Slominski A; Pruski D
    Exp Cell Res; 1993 Jun; 206(2):189-94. PubMed ID: 8500544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term cultivation of a human breast cancer cell line, MCF-7, in a chemically defined medium. Effect of estradiol.
    Briand P; Lykkesfeldt AE
    Anticancer Res; 1986; 6(1):85-90. PubMed ID: 3513694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.